Sexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway - Skj ælaaen K, Nesvold H, Brekke M, Sare M, Landaas ET, Mdala I, Olsen AO, Vallersnes OM.
OBJECTIVES: We estimate the prevalence of sexually transmitted infection (STI) among patients after sexual assault, assess the possible value of azithromycin prophylaxis, and identify risk factors for assault-related STI and for not presenting at follow-up... (Source: SafetyLit)
Source: SafetyLit - December 5, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Platform trial rules out treatments for COVID-19, NIHR Evidence
This research shows that adding doxycycline, azithromycin or colchicine to usual care provides no meaningful benefit to people in the community with COVID-19. They should not be used. Antibiotics should always be used sparingly to prevent bacteria becoming resistant to them. Use of any drug which is not effective puts people at unnecessary risk of side effects, and wastes money. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 18, 2022 Category: Consumer Health News Source Type: news
Azithromycin Improves Outcomes in Poorly Controlled Child Asthma
Better control, fewer exacerbations seen with addition of oral azithromycin to standard therapy in children with poorly controlled asthma (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 20, 2022 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
Azithromycin Improves Outcomes in Poorly Controlled Child Asthma
MONDAY, June 20, 2022 -- Azithromycin helps improve asthma control and reduce exacerbations in children with poorly controlled asthma, according to a study published in the June issue of CHEST.
Jagat Jeevan Ghimire, M.D., from All India Institute... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 20, 2022 Category: Pharmaceuticals Source Type: news
NIHR Alert: Platform trial rules out treatments for COVID-19, NIHR
Expert commentary is provided for a trial which found adding doxycycline, azithromycin or colchicine to usual care provides no benefit to people in the community with COVID-19. These data are useful as preventing ineffective antibiotic use is critical to reduce drug resistance. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 6, 2022 Category: Consumer Health News Source Type: news
Doxycycline Bests Azithromycin for Anogenital Chlamydia in Women
(MedPage Today) -- Doxycycline was superior to azithromycin for women with both anorectal and vaginal Chlamydia trachomatis infections, French researchers found in an open-label randomized trial.
In a modified intention-to-treat analysis, microbiological... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 10, 2022 Category: Infectious Diseases Source Type: news
azithromycin (Zithromax): For COVID-19
Title: azithromycin (Zithromax): For COVID-19Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 4/4/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 4, 2022 Category: Drugs & Pharmacology Source Type: news
Essential medicines to get expensive from April
The NLEM list includes drugs like paracetamol, antibiotics like azithromycin, used to treat bacterial infections, anti-anaemia, vitamins and minerals. Some drugs used for treating moderately to severely ill Covid-19 patients and steroids are also included in the list. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2022 Category: Pharmaceuticals Source Type: news
Essential medicines to get expensive by more than 10 per cent from April
The NLEM list includes drugs like paracetamol, antibiotics like azithromycin, used to treat bacterial infections, anti-anaemia, vitamins and minerals. Some drugs used for treating moderately to severely ill Covid-19 patients and steroids are also included in the list. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 25, 2022 Category: Pharmaceuticals Source Type: news
Azithromycin Therapy Does Not Reduce Recurrent Wheeze After RSV
MONDAY, March 14, 2022 -- Azithromycin therapy during acute severe respiratory syncytial virus (RSV) bronchiolitis does not reduce recurrent wheeze over two to four years, according to a study published online Feb. 27 in NEJM Evidence.
Avraham... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2022 Category: Pharmaceuticals Source Type: news
Azithromycin Doesn't Prevent Wheezing After Acute Infant RSV Azithromycin Doesn't Prevent Wheezing After Acute Infant RSV
Azithromycin administered for severe early-life respiratory syncytial virus bronchiolitis did not prevent recurrent wheezing in affected children over the next 2-4 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2022 Category: Consumer Health News Tags: Pediatrics News Source Type: news
Alembic Pharma net profit drops 40% to Rs 176 crore in Q3FY22
"India business is going to grow, and continue to grow faster than our represented market, the initiatives we have taken in last few years and the Omicron coming up in the last quarter - some of the COVID related therapies like Azithromycin have seen sharp uptake in January," Pranav Amin, managing director, international business at Alembic Pharma told ET. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 10, 2022 Category: Pharmaceuticals Source Type: news
Antibiotics for the treatment of COVID19, Cochrane Database of Systematic Reviews
Review of 11 studies (n=11,281) found evidence of high certainty that azithromycin does not reduce risk of death in hospitalised COVID ‐19 patients and of moderate certainty that it does not attenuate clinical worsening or improvement. There is no evidence for other antibiotics. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 3, 2022 Category: Consumer Health News Source Type: news
Antibiotics for the treatment of COVID19, Cochrane Library
Main results We included 11 studies with 11,281 participants with an average age of 54 years investigating antibiotics compared to placebo, standard of care alone or another antibiotic. No study was found comparing antibiotics to an intervention with proven efficacy. All studies investigated azithromycin, two studies investigated other antibiotics compared to azithromycin. Seven studies investigated inpatients with moderate to severe COVID ‐19 and four investigated mild COVID‐19 cases in outpatient settings. Eight studies had an open‐label design, two were blinded with a placebo control, and one did not report on bli...
Source: Current Awareness Service for Health (CASH) - November 22, 2021 Category: Consumer Health News Source Type: news
Hydroxychloroquine sales spiked almost 100% in Australia at start of Covid pandemic, study finds
There was also a rise in prescriptions for ivermectin being filled, despite no evidence either drug is effective against the virusThe amount of hydroxychloroquine and ivermectin dispensed from Australian pharmacies increased significantly in 2020 as the Covid pandemic took hold, according to new research.Analysis of six publicly subsidised drugs – including hydroxychloroquine, ivermectin, corticosteroids and the common antibiotic azithromycin – found Covid-related changes in prescription patterns in Australia.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 30, 2021 Category: Science Authors: Donna Lu Tags: Health Coronavirus Drugs Medical research Australia news Source Type: news
